Biotechnology
OVID
1.39
price up icon1.46%   0.02
after-market Handel nachbörslich: 1.41 0.02 +1.44%

Ovid Therapeutics Inc (OVID)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose
Schlusskurs vom Vortag:
$1.37
Offen:
$1.36
24-Stunden-Volumen:
1.67M
Relative Volume:
0.60
Marktkapitalisierung:
$98.84M
Einnahmen:
$391.70K
Nettoeinkommen (Verlust:
$-52.34M
KGV:
-1.8533
EPS:
-0.75
Netto-Cashflow:
$-45.92M
1W Leistung:
-14.72%
1M Leistung:
+6.92%
6M Leistung:
+324.95%
1J Leistung:
+23.01%
1-Tages-Spanne:
Value
$1.34
$1.46
1-Wochen-Bereich:
Value
$1.34
$1.73
52-Wochen-Spanne:
Value
$0.2425
$2.01

Ovid Therapeutics Inc Stock (OVID) Company Profile

Name
Firmenname
Ovid Therapeutics Inc
Name
Sektor
Healthcare (1135)
Name
Branche
Biotechnology (635)
Name
Telefon
212-776-4381
Name
Adresse
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Name
Mitarbeiter
23
Name
Twitter
@OvidRx
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
OVID's Discussions on Twitter

Vergleichen Sie OVID mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OVID
Ovid Therapeutics Inc
 1.39 97.42M 391.70K -52.34M -45.92M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-09 Eingeleitet Oppenheimer Outperform
2025-08-08 Fortgesetzt B. Riley Securities Buy
2024-06-18 Herabstufung Oppenheimer Outperform → Perform
2024-04-30 Eingeleitet B. Riley Securities Buy
2024-04-29 Eingeleitet H.C. Wainwright Buy
2024-04-05 Eingeleitet Wedbush Outperform
2023-12-21 Eingeleitet BTIG Research Buy
2023-10-13 Eingeleitet Oppenheimer Outperform
2021-04-20 Herabstufung Cantor Fitzgerald Buy → Neutral
2021-03-03 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2020-12-02 Herabstufung Citigroup Buy → Neutral
2020-12-02 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2019-09-04 Eingeleitet RBC Capital Mkts Outperform
2018-04-20 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Ovid Therapeutics Inc Aktie (OVID) Neueste Nachrichten

pulisher
Nov 02, 2025

Can trapped investors hope for a rebound in Ovid Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What analysts say about Ovid Therapeutics Inc 1OT stockSector Leadership Analysis & Low Risk Capital Appreciation - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

How Ovid Therapeutics Inc. (1OT) stock correlates with oil markets2025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Combining machine learning predictions for Ovid Therapeutics Inc.Watch List & Technical Buy Zone Confirmation - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Visual analytics tools that track Ovid Therapeutics Inc. performanceM&A Rumor & Risk Managed Investment Entry Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Long term hold vs stop loss in Ovid Therapeutics Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockQuarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Ovid Therapeutics Inc. (1OT) stock protected from inflation2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

How strong is Ovid Therapeutics Inc. stock balance sheetJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Using flow based indicators on Ovid Therapeutics Inc.Market Performance Summary & AI Driven Price Forecasts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Short Interest in Ovid Therapeutics (NASDAQ:OVID) Grows By 463.2% - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Quarterly Recap: How Ovid Therapeutics Inc. stock compares to industry benchmarksEarnings Summary Report & Weekly Sector Rotation Insights - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

OVID PRE 14A: approvals for Series B conversion and warrants - Stock Titan

Oct 28, 2025
pulisher
Oct 27, 2025

OVID special meeting to approve PIPE share issuances and 315M authorization - Stock Titan

Oct 27, 2025

Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie OVID

biotechnology RPRX
$37.54
price up icon 1.62%
biotechnology INCY
$93.48
price up icon 0.96%
biotechnology GMAB
$28.61
price down icon 0.21%
biotechnology BNTX
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
biotechnology INSM
$189.60
price down icon 2.38%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):